These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

918 related items for PubMed ID: 18797405

  • 1. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 2. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 3. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S.
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [Abstract] [Full Text] [Related]

  • 4. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 6. Waltz dancing in patients with chronic heart failure: new form of exercise training.
    Belardinelli R, Lacalaprice F, Ventrella C, Volpe L, Faccenda E.
    Circ Heart Fail; 2008 Jul; 1(2):107-14. PubMed ID: 19808280
    [Abstract] [Full Text] [Related]

  • 7. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 8. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 9. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 10. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 05; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 11. Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    Belardinelli R, Solenghi M, Volpe L, Purcaro A.
    Eur Heart J; 2007 May 05; 28(9):1102-8. PubMed ID: 17456483
    [Abstract] [Full Text] [Related]

  • 12. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure.
    Belardinelli R, Lacalaprice F, Faccenda E, Purcaro A, Perna G.
    Int J Cardiol; 2005 May 11; 101(1):83-90. PubMed ID: 15860388
    [Abstract] [Full Text] [Related]

  • 13. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R, Capestro F, Misiani A, Scipione P, Georgiou D.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 11; 13(5):818-25. PubMed ID: 17001224
    [Abstract] [Full Text] [Related]

  • 14. Influence of exercise training on left ventricular diastolic function and its relationship to exercise capacity in patients after myocardial infarction.
    Korzeniowska-Kubacka I, Bilińska M, Michalak E, Kuśmierczyk-Droszcz B, Dobraszkiewicz-Wasilewska B, Piotrowicz R.
    Cardiol J; 2010 Oct 11; 17(2):136-42. PubMed ID: 20544611
    [Abstract] [Full Text] [Related]

  • 15. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL.
    Cardiologia; 1999 Dec 11; 44(12):1065-9. PubMed ID: 10687257
    [Abstract] [Full Text] [Related]

  • 16. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Am J Cardiol; 2006 Sep 04; 98(5A):25J-33J. PubMed ID: 16931203
    [Abstract] [Full Text] [Related]

  • 17. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 04; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 18. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM, Baksheev VI, Uvaĭsova KU.
    Klin Med (Mosk); 2008 Nov 04; 86(6):38-43. PubMed ID: 18720710
    [Abstract] [Full Text] [Related]

  • 19. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV).
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep 09; 33(9):793-5. PubMed ID: 16266453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.